WST West Pharmaceutical Services Inc

  1. Stocks
  2. Healthcare
  3. NYSE: WST

Price (delayed)

$360.43

Market cap

$26.25B

P/E Ratio

46.99

Dividend/share

$0.79

EPS

$7.67

Enterprise value

$25.96B

West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, ...

Highlights
The stock's price to earnings (P/E) is 6% less than its last 4 quarters average of 50.2
WST's debt is down by 2.5% year-on-year
WST's EPS is down by 3.9% since the previous quarter but it is up by 3.5% year-on-year
The net income has contracted by 4.2% from the previous quarter but it has grown by 3% YoY
West Pharmaceutical Services's quick ratio has decreased by 34% YoY and by 14% from the previous quarter
WST's equity is down by 7% since the previous quarter and by 3.4% year-on-year
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.westpharma.com
Peers: BDX ICUI SYK BAX

Key stats

What are the main financial stats of WST
Market
Shares outstanding
72.84M
Market cap
$26.25B
Enterprise value
$25.96B
Valuations
Price to earnings (P/E)
46.99
Price to book (P/B)
9.86
Price to sales (P/S)
9.05
EV/EBIT
37.5
EV/EBITDA
31.15
EV/Sales
8.86
Earnings
Revenue
$2.93B
EBIT
$692.2M
EBITDA
$833.5M
Free cash flow
$386.1M
Per share
EPS
$7.67
Free cash flow per share
$5.25
Book value per share
$36.57
Revenue per share
$39.84
TBVPS
$47.36
Balance sheet
Total assets
$3.6B
Total liabilities
$921.7M
Debt
$306.6M
Equity
$2.68B
Working capital
$1.04B
Liquidity
Debt to equity
0.11
Current ratio
2.61
Quick ratio
1.74
Net debt/EBITDA
-0.35
Margins
EBITDA margin
28.5%
Gross margin
37.2%
Net margin
19.4%
Operating margin
22%
Efficiency
Return on assets
15.3%
Return on equity
20.4%
Return on invested capital
27.5%
Return on capital employed
23.4%
Return on sales
23.6%
Dividend
Dividend yield
0.22%
DPS
$0.79
Payout ratio
10.3%

WST stock price

How has the West Pharmaceutical Services stock price performed over time
Intraday
-2.1%
1 week
-3.12%
1 month
-7.16%
1 year
0.9%
YTD
2.36%
QTD
-8.92%

Financial performance

How have West Pharmaceutical Services's revenue and profit performed over time
Revenue
$2.93B
Gross profit
$1.09B
Operating income
$643.5M
Net income
$568.7M
Gross margin
37.2%
Net margin
19.4%
The operating margin has declined by 9% year-on-year and by 3.9% since the previous quarter
WST's operating income is down by 8% YoY and by 4.8% from the previous quarter
West Pharmaceutical Services's gross margin has decreased by 4.4% YoY and by 2.9% from the previous quarter
The gross profit has contracted by 3.6% from the previous quarter and by 3.1% YoY

Growth

What is West Pharmaceutical Services's growth rate over time

Valuation

What is West Pharmaceutical Services stock price valuation
WST P/E details
P/E
46.99
P/B
9.86
P/S
9.05
EV/EBIT
37.5
EV/EBITDA
31.15
EV/Sales
8.86
The stock's price to earnings (P/E) is 6% less than its last 4 quarters average of 50.2
WST's EPS is down by 3.9% since the previous quarter but it is up by 3.5% year-on-year
WST's equity is down by 7% since the previous quarter and by 3.4% year-on-year
The P/S is 6% below the last 4 quarters average of 9.6 but 5% above the 5-year quarterly average of 8.6

Efficiency

How efficient is West Pharmaceutical Services business performance
WST's return on invested capital is down by 4.8% since the previous quarter and by 3.8% year-on-year
West Pharmaceutical Services's ROE has decreased by 4.2% YoY and by 3.3% from the previous quarter
WST's return on sales is down by 4.1% since the previous quarter
The company's return on assets fell by 3.2% QoQ and by 3.2% YoY

Dividends

What is WST's dividend history
DPS
$0.79
Dividend yield
0.22%
Payout ratio
10.3%
Recent dividends

Financial health

How did West Pharmaceutical Services financials performed over time
West Pharmaceutical Services's quick ratio has decreased by 34% YoY and by 14% from the previous quarter
West Pharmaceutical Services's current ratio has decreased by 28% YoY and by 9% QoQ
WST's debt is 89% smaller than its equity
WST's equity is down by 7% since the previous quarter and by 3.4% year-on-year
WST's debt is down by 2.5% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.